Subscribe to RSS
DOI: 10.1055/s-2004-835965
Interleukin-6 and Tumor Necrosis Factor Alpha as Predictors of Success after Emergent Cerclage
Publication History
Publication Date:
06 December 2004 (online)
![](https://www.thieme-connect.de/media/ajp/200408/lookinside/thumbnails/10.1055-s-2004-835965-1.jpg)
ABSTRACT
Serum levels of interleukin-6 (IL-6) and tumor necrosis factor alpha (TNF-α) were measured in patients requiring an emergent cerclage to determine if they are predictive of successful pregnancy outcome. Women with a clinical diagnosis of cervical incompetence requiring an emergent cerclage between 15 and 24 weeks gestation were enrolled. Asymptomatic women of the same gestational age range were recruited as controls. IL-6 and TNF-α levels were measured by enzyme-linked immunosorbent assay. Twenty-one women underwent emergent cerclage and participated in the study, 15 (71%) of whom delivered after 28 weeks. Twenty-one women served as controls. IL-6 levels were increased in women with cervical incompetence compared with control subjects, but there were no differences between cerclage success and failure groups. TNF-α was not increased in women with cervical incompetence and did not predict success of emergent cerclage. IL-6 levels were increased in women with cervical incompetence who required an emergent cerclage.
KEYWORDS
Cervical incompetence - emergent cerclage - IL-6 - TNF-α - inflammation
REFERENCES
- 1 Iams J. Cervical incompetence. In: Creasy R, Resnik R Maternal-Fetal Medicine Philadelphia; W.B. Saunders 1999: 445-464
- 2 Ansari A H, Reynolds R A. Cervical incompetence: a review. J Reprod Med. 1987; 32 161-171
- 3 Golan A, Barnan R, Wexler S, Langer R, Bukovsky I, David M P. Incompetence of the uterine cervix. Obstet Gynecol Surv. 1989; 44 96-107
- 4 Romero R, Gonzalez R, Sepulveda W. Microbial invasion of the amniotic cavity in patients with suspected cervical incompetence: prevalence and clinical significance. Am J Obstet Gynecol. 1992; 167 1086-1091
- 5 Oberholzer A, Oberholzer C, Moldawer L. Cytokine signaling-regulation of the immune response in normal and critically ill states. Critical Care Med. 2000; 28 N3-N12
- 6 Romero R, Mazor M, Sepulveda W, Copeland D, Williams J. Tumor necrosis factor in preterm and term labor. Am J Obstet Gynecol. 1992; 166 1567-1587
- 7 Hillier S L, Witkin S S, Krohn M A, Watts D N, Kiviat N B, Eschenbach D A. The relationship of amniotic fluid cytokines and preterm delivery, amniotic fluid infection, histiologic chorioamnionitis, and chorioamnion infection. Obstet Gynecol. 1993; 81 941-948
- 8 Goldenberg R, Hauth J, Andrews W. Mechanisms of disease: intrauterine infection and preterm delivery. New Engl J Med. 2000; 342 1500-1507
- 9 Novy M, Gupta A, Wothe D, Gupta S, Kennedy K, Gravett M. Cervical cerclage in the second trimester of pregnancy: a historical cohort study. Am J Obstet Gynecol. 2001; 184 1447-1456
- 10 Olatunbosum O A, al-Nuaim L, Turnell R W. Emergency cerclage compared with bedrest for advanced cervical dilation in pregnancy. Int Surg. 1995; 80 170-174
- 11 Schorr S, Morales W. Obstetric management of incompetent cervix and bulging fetal membranes. J Reprod Med. 1996; 41 235-238
- 12 MacDougall J, Siddle N. Emergency cervical cerclage. Br J Obstet Gynecol. 1991; 98 1234-1238
- 13 Chasen S, Siverman N. Mid-trimester emergent cerclage: a ten year single institution review. J Perinatol. 1998; 18 338-342
- 14 Aarts J, Brons J, Bruinse H. Emergency cerclage: a review. Obstet Gynecol Surv. 1995; 50 459-469
- 15 Kurup M, Goldkrand J. Cervical incompetence: elective, emergent, or urgent cerclage. Am J Obstet Gynecol. 1999; 181 240-246
- 16 Exley A, Cohen J. Optimal collection of blood samples for the measurement of tumor necrosis factor alpha. Cytokine. 1990; 2 353-356
- 17 Thavasu P W, Longhurst S, Joel S P, Slevin M L, Balkwill F R. Measuring cytokine levels in blood. Importance of anticoagulants, processing, and storage conditions. J Immunol Methods. 1992; 153 115-124
- 18 Weiyuan Z, Li W. Study of interleukin-6 and tumor necrosis factor-α levels in maternal serum and amniotic fluid of patients with premature rupture of membranes. J Perinat Med. 1998; 26 491-494
- 19 Greig P, Murtha A, Jimmerson C, Herbert W, Roitman-Johnson B, Allen J. Maternal serum interleukin-6 during pregnancy and during term and preterm labor. Obstet Gynecol. 1997; 90 465-469
- 20 Murtha A, Greig P, Jimmerson C, Herbert W. Maternal serum interleukin-6 concentration as a marker for impending preterm delivery. Obstet Gynecol. 1998; 91 161-164
Loraine K EndresM.D.
Division of Maternal-Fetal Medicine, University of Illinois
820 S. Wood Street, MC 808
Chicago, IL 60612